immune control;
immune-based therapies;
HIV;
highly active antiretroviral therapy;
D O I:
10.1093/jac/dkh132
中图分类号:
R51 [传染病];
学科分类号:
100401 ;
摘要:
The recent success of highly active antiretroviral therapy (HAART) has altered the prognosis of patients living with HIV-1 infection. However, there are still many challenges to be addressed if we want to develop long-term therapeutic strategies for patients, in both the Western world and resource-poor countries. In this review, the potential role for HIV-1 therapeutic vaccines in the era of HAART will be discussed in the light of the present efforts at developing immune-based therapies to complement antiviral treatment and minimize the duration of exposure to antiviral drugs.
机构:
John Radcliffe Hosp, MRC Human Immunol Unit, Weatherall Inst Mol Med, Oxford OX3 9DS, EnglandJohn Radcliffe Hosp, MRC Human Immunol Unit, Weatherall Inst Mol Med, Oxford OX3 9DS, England
机构:
US Mil, HIV Res Program, Walter Reed Army Inst Res, Silver Spring, MD 20910 USA
Adv Mil Med Inc, Henry M Jackson Fdn, Bethesda, MD 20817 USAUS Mil, HIV Res Program, Walter Reed Army Inst Res, Silver Spring, MD 20910 USA